Historical record - last NADAC effective date: 11/19/2014
Product Information
ZIDOVUDINE 100 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $1.3658 per EA under NDC 65862010701. Its NADAC has been published 108 times since Nov 28, 2013.
FDA first approved this application on Mar 27, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862010701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
11/19/2014
Active Ingredients
ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA078128FDA Approved
3/27/2006
TE Code
AB
On Market Since
3/27/2006
Pharmacological Classes
Price Statistics
The NADAC for ZIDOVUDINE 100 MG CAPSULE has been published 108 times since Nov 28, 2013, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3658 per EA |
|---|---|
| All-time high | $1.3658 (Dec 16, 2015) |
| All-time low | $1.2475 (Jan 22, 2014) |
| Median price | $1.3658 |
| Average price | $1.3161 |
| Largest weekly change | +9.5% (Nov 19, 2014) |
| Weeks tracked | 108 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+2.7%
Last surveyed Dec 16, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Zidovudine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zidovudine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZIDOVUDINE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZIDOVUDINE 100 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $1.3658 per EA (NDC 65862010701), effective Dec 16, 2015.
How has the price of ZIDOVUDINE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZIDOVUDINE 100 MG CAPSULE has risen 2.7%. It has been tracked across 108 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZIDOVUDINE 100 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ZIDOVUDINE 100 MG CAPSULE has ranged from a low of $1.2475 (Jan 22, 2014) to a high of $1.3658 (Dec 16, 2015), with a median of $1.3658 per EA.
Are there cheaper alternatives to ZIDOVUDINE 100 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ZIDOVUDINE 100 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZIDOVUDINE 100 MG CAPSULE?
ZIDOVUDINE 100 MG CAPSULE (NDC 65862010701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.